Neoantigen-Based Cancer Vaccines: Current Innovations, Challenges and Future Directions in Personalized Immunotherapy
Targeted Cancer Therapy Connect · 21.10.2024 · 1 (1) · 1
DOI: 10.69709/ciconnect.2024.194763 ↗Kurz gefasst
Fachartikel in der Zeitschrift Targeted Cancer Therapy Connect, online erschienen am 21.10.2024. Verfasst von Saad Ahmed und 2 weiteren Autor:innen. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 54 Literaturangaben.
Abstract (Originalsprache)
The development of neoantigen-based cancer vaccines represents a breakthrough in personalized immunotherapy due to their ability to elicit strong and effective tumor-specific immune responses. Unlike conventional cancer vaccines, neoantigen vaccines target mutations found explicitly in tumor cells, thus maximizing specificity and minimizing immune tolerance. The review explores the current status of neoantigen vaccines and their mechanisms, development, and clinical applications. In contrast, it also explores the challenges of personalized vaccines, such as identifying neoantigens and their manufacturing, along with biological factors and regulatory hurdles. Future innovations and strategies are discussed to overcome resistance and relapse. Critical issues like global access, equity, and scalability must be addressed for its more comprehensive implementation. This review article discusses the potential of neoantigen vaccines in cancer therapy, detailing ongoing research and clinical trials, while addressing the persistent challenges that must not be underestimated.
Zitieren
APA
Ahmed, S., Mazhar, M. S., & Shabbir, M. F. (2024). Neoantigen-Based Cancer Vaccines: Current Innovations, Challenges and Future Directions in Personalized Immunotherapy. Targeted Cancer Therapy Connect, 1(1), 1. https://doi.org/10.69709/ciconnect.2024.194763
Vancouver
Ahmed S, Mazhar MS, Shabbir MF. Neoantigen-Based Cancer Vaccines: Current Innovations, Challenges and Future Directions in Personalized Immunotherapy. Targeted Cancer Therapy Connect. 2024;1(1):1. doi:10.69709/ciconnect.2024.194763
BibTeX
@article{Ahmed2024,
author = {Ahmed, Saad and Mazhar, Muhammad Shayaan and Shabbir, Muhammad Fahad},
title = {Neoantigen-Based Cancer Vaccines: Current Innovations, Challenges and Future Directions in Personalized Immunotherapy},
journal = {Targeted Cancer Therapy Connect},
year = {2024},
volume = {1},
number = {1},
pages = {1},
doi = {10.69709/ciconnect.2024.194763}
}
EUVIMED